Search - tctmd.com

Displaying 81 - 98 of 98

Sort: Relevancy | Date

News Daily News

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

Todd Neale

March 06, 2016

News Daily News

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Shelley Wood

February 23, 2016

News Daily News

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Yael L. Maxwell

November 24, 2015

News Daily News

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

L.A. McKeown

August 19, 2015

News Industry News

First Aortic Valve Procedure With Newly Approved Device Performed at NYU Langone

July 29, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Conference News EuroPCR 2015

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Yael L. Maxwell

May 22, 2015

News Daily News

Study Provides Insight Into Cerebral Embolization During TAVR

April 29, 2015

News Daily News

TVT Registry Provides Picture of TAVR Risk Factors, 1-Year Outcomes

L.A. McKeown

March 10, 2015

News Daily News

Major Bleeds Late After TAVR Not Only Frequent But Portend Worse Outcomes

Todd Neale

December 16, 2014

News Daily News

Periprocedural TAVR Complications Common, Costly

L.A. McKeown

November 02, 2014

News Conference News ACC 2014

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Yael L. Maxwell

March 29, 2014

News Daily News

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Yael L. Maxwell

September 27, 2013

News Daily News

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

May 24, 2013

News Daily News

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

Yael L. Maxwell

August 09, 2012

News Daily News

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

July 19, 2012

News Conference News ACC 2012

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

March 26, 2012

News

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

TCT Daily Staff

September 23, 2010

Advertisement

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

First Aortic Valve Procedure With Newly Approved Device Performed at NYU Langone

MVARC Document Offers Template for Mitral Valve Therapeutics Research

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Study Provides Insight Into Cerebral Embolization During TAVR

TVT Registry Provides Picture of TAVR Risk Factors, 1-Year Outcomes

Major Bleeds Late After TAVR Not Only Frequent But Portend Worse Outcomes

Periprocedural TAVR Complications Common, Costly

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Registry: 1-Year Mortality Similar for TAVR, Surgery in Intermediate-Risk Patients

JAMA Viewpoint: TAVR Promise Must Be Weighed Against Risks, Limitations

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content